Table 3.
Patient response to second-line chemotherapy (n = 54)
| Variable | CR+PR | SD+PD | P-value | CR+PR+SD | PD | P-value |
|---|---|---|---|---|---|---|
| CC3 expression | ||||||
| Negative | 5 | 23 | 0.218 | 11 | 17 | 0.033 |
| Positive | 9 | 17 | 18 | 8 | ||
| Ki-67 risk | ||||||
| ≤ 30% | 3 | 9 | 1.000 | 10 | 2 | 0.024 |
| > 30% | 11 | 31 | 19 | 23 | ||
| E-cad | ||||||
| Negative | 4 | 13 | 1.000 | 5 | 12 | 0.020 |
| Positive | 10 | 27 | 24 | 13 |
CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.